Press Release
Organizational and Personnel Changes of ASKA Pharmaceutical
TOKYO, August 26, 2022 - ASKA Pharmaceutical Holdings Co., Ltd. (Headquarters: Minato-
ku, Tokyo/ President, Representative Director: Takashi Yamaguchi, hereinafter "ASKA") announced the following organizational and personnel changes of its subsidiary, ASKA Pharmaceutical Co., Ltd., effective October 1, 2022, respectively.
-
Organizational Change
To reinforce the monitoring system for sales information provision activities, a new department independent from each division will be established. - The "Sales Information Provision Supervisory Team" of Quality & Safety Assurance Division will be renamed the "Information service Supervisory Unit" and will become an independent organization.
- Change of Corporate Officer's Responsibilities.
[New Responsibilities]
Corporate Officer, Director of Information service Supervisory Unit (Corporate Officer, In Charge of Audit and Legal Affairs & Regulatory
Kunihiro Gunji Compliance of ASKA Pharmaceutical Holdings Co., Ltd.) [Current Responsibilities]
Administrative Division * Seconded to ASKA Pharmaceutical Holdings Co., Ltd. (Corporate Officer, In Charge of Audit and Legal Affairs & Regulatory Compliance of ASKA Pharmaceutical Holdings Co., Ltd.)
3. Personnel Appointments
[New Responsibilities] | |
Assistant Division Director of Innovative Drug Discovery Division | |
(Concurrently works in Portfolio Management Department) | |
Yasuhiro Tsukimi | [Current Responsibilities] |
Assistant Division Director of Innovative Drug Discovery Division | |
Director of Drug Discovery Department | |
(Concurrently works in Portfolio Management Department) | |
[New Responsibilities] | |
Assistant Division Director of Production Division | |
Kazuhiro Sasaki | Director of Pharmaceutical Technology Department |
[Current Responsibilities] | |
Director of Pharmaceutical Technology Department, Production Division |
1/2
[New Responsibilities] | |
Director of Drug Discovery Department, Innovative Drug Discovery Division | |
Masayuki | * concurrently continues as Manager of Drug Discovery Department |
Yoshizawa | [Current Responsibilities] |
Manager of Drug Discovery Department, Innovative Drug Discovery | |
Division | |
[New Responsibilities] | |
Director of Quality Assurance Department, Quality & Safety Assurance | |
Kenichi Tajima | Division * Quality Assurance Manager |
[Current Responsibilities] | |
Manager of Quality Assurance Department, Quality & Safety Assurance | |
Division | |
[New Responsibilities] | |
Chiaki Neuchi | Director of Quality Control Department, Iwaki Factory, Production Division |
[Current Responsibilities] | |
Manager of Manufacturing Department, Iwaki Factory, Production Division | |
[New Responsibilities] | |
Director of North Japan Sales Department, Sales Division | |
Takashi Ishimori | [Current Responsibilities] |
Manager of Sapporo Sales Office, North Japan Sales Department, Sales | |
Division | |
[New Responsibilities] | |
Akira Hasegawa | Director of West Japan Sales Department Region 2, Sales Division |
[Current Responsibilities] | |
Director of East Japan Sales Department Region 2, Sales Division | |
[New Responsibilities] | |
Director of East Japan Sales Department Region 2, Sales Division | |
Takeshi Okoshi | [Current Responsibilities] |
Manager of Saitama Sales Office, East Japan Sales Department Region 2, | |
Sales Division |
Media Contacts
ASKA Pharmaceutical Holdings Co., Ltd.
Corporate Planning Department
Tel: +81-3-5484-8366
Email: kouhou@aska-pharma.co.jp
2/2